semaglutide blindness risk Big headlines this past week about and due to something called NAION (nonarteritic anterior ischemic optic neuropathy). We spoke with our buddy Dr. Brugger, an ophthalmologist, all about it. Take Popular weight loss and diabetes
Description
The results of this study found that GLP-1 receptor agonists are associated with significantly reduced rates of new substance use disorders across every major addictive substance studied, including alcohol and nicotine
Injection sites are rotated with each dose to avoid irritation
Who Should (and Shouldn't) Take GLP-1 Medications
Summary Mounjaro effectively manages weight and type 2 diabetes when used appropriately
